Advertisement

Psychiatric Complications of Sulfur Mustard (SM) Poisoning

  • Mohammad Reza Fayyazi BordbarEmail author
  • Farhad Faridhosseini
  • Ali Saghebi
Chapter

Abstract

Study of Sulfur Mustard (SM) effects on the central nervous system and its neuro-psychiatric complications have been proved difficult to deal with. In the First World War, and the Iran-Iraq war SM was extensively used and its medical and psychological complications can still be observed in the veterans years later. We have tried to include the findings of all available research literature regarding the neuro-psychiatric complications of SM.

The popular neurological complications attributed to SM exposure include: headache, fatigue, chronic neuropathy, impaired memory and concentration, and seizure. Post-traumatic stress disorder (PTSD) is one of the most common psychiatric disorders due to combat experience, especially chemical warfare agents (CWA) including SM. Its clinical features, and pharmacological and psychological treatments are covered in this chapter.

Other psychiatric complications commonly observed in the victims of SM exposure are: depression, anxiety, sleep disorders and sexual dysfunctions. Clinical features and treatment options of each disorder, in addition to their incidence and prevalence rates are discussed.

The last but not the least are the changes in quality of life of these patients due to chronic medical and psychological complications of SM exposure.

All in all, it’s safe to say that the neuro-psychiatric complications are serious and quite common outcome of SM exposure and need specific clinical attention.

Keywords

PTSD Anxiety Neuropathy Headache Depression Sulfur mustard Poisoning Psychological complications 

References

  1. Abbasi S, Mehdizadeh S, Payami-Bousar M (2012) Relationship between general health level and sleep quality in chemical warfare victims with bronchiolitis obliterans. Iran J Mil Med 14(1):15–19Google Scholar
  2. Ahmadi K, Reshadatjoo M, Karami GR (2010) Comparison of depression, anxiety and stress rate between chemical warfare victims and healthy persons in Sardasht; Iran. J Babol Univ Med Sci 12(1):44–50Google Scholar
  3. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders. American Psychiatric Publishing, ArlingtonCrossRefGoogle Scholar
  4. Anslow WP, Houk CR (1946) Systemic pharmacology and pathology of sulphur and nitrogen mustard in: chemical warfare agents and related chemical problems. National Defense Research Committee, Washington DC, pp 440–478Google Scholar
  5. Balali-Mood M (1992) Evaluation of late toxic effects of sulfur mustard poisoning in 1428 Iranian veterans. In: Veteran Foundation (ed) The seminar on late complications of chemical warfare agents in Iranian veterans. Tehran, IranGoogle Scholar
  6. Balali-Mood M, Balali-Mood K (2008) Neurotoxic disorders of organophosphorus compounds and their managements. Arch Iran Med 11:65–89PubMedGoogle Scholar
  7. Balali-Mood M, Hefazi M (2005) The pharmacology, toxicology, and medical treatment of sulfur mustard poisoning. Fundam Clin Pharmacol 19:297–315CrossRefPubMedGoogle Scholar
  8. Balali-Mood M, Hefazi M (2006) Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 99:273–282CrossRefPubMedGoogle Scholar
  9. Balali-Mood M, Navaeian A (1986) Clinical and paraclinical findings in 233 patients with sulfur mustard poisoning. In: Heyndrickx B (ed) Proceedings of the second world congress on New compounds in biological and chemical warfare: toxicological evaluation. Ghent University Press, Ghent, Belgium, pp 464–473Google Scholar
  10. Balali-Mood M, Hefazi M, Mahmoudi M et al (2005) Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundam Clin Pharmacol 9:713–721. doi: 10.1111/j.1472-8206.2005.00364.x CrossRefGoogle Scholar
  11. Balali-Mood M, Mousavi SH, Balali-Mood B (2008) Chronic health effects of sulphur mustard exposure with special reference to Iranian veterans. Emerg Health Threats J 1:e7. doi: 10.3134/ehtj.08.007 PubMedPubMedCentralGoogle Scholar
  12. Baldwin DS, Allgulander C, Bandelow B et al (2012) An international survey of reported prescribing practice in the treatment of patients with generalised anxiety disorder. World J Biol Psychiatry 13(7):510–516. doi: 10.3109/15622975.2011.624548 CrossRefPubMedGoogle Scholar
  13. Baldwin DS, Anderson IM, Nutt DJ et al (2014) Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol 28(5):403–439. doi: 10.1177/0269881114525674 CrossRefPubMedGoogle Scholar
  14. Beard C, Weisberg RB, Keller MB (2010) Health-related quality of life across the anxiety disorders: findings from a sample of primary care patients. J Anxiety Disord 24(6):559–564. doi: 10.1016/j.janxdis.2010.03.015 CrossRefPubMedPubMedCentralGoogle Scholar
  15. Berger W, Mendlowicz MV, Marques-Portella C et al (2009) Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry 33(2):169–180CrossRefPubMedGoogle Scholar
  16. Biat Saeed K, Parandeh A, Alhani F et al (2014) Health-related quality of life of chemical warfare victims: an assessment with the use of a specific tool. Trauma Mon 19(1):e13800CrossRefPubMedPubMedCentralGoogle Scholar
  17. Bitran S, Barlow DH, Spiegel DA (2012) Generalized anxiety disorders. In: Gelder MG, Andreasen NC, Lopez-Ibor JJ, Geddes JR (eds) New oxford textbook of psychiatry, 2nd edn. Oxford University Press, Oxford, pp 729–739Google Scholar
  18. Blacker D (2009) Psychiatric rating scales. In: Sadock BJ, Sadock VA, Ruiz P (eds) Kaplan and Sadock’s comprehensive textbook of psychiatry, 9th edn. Lippincott, Williams and Wilkins, Philadelphia, pp 1033–1059Google Scholar
  19. Comer RJ (2010) Abnormal psychology, 7th edn. Worth Publishers, New YorkGoogle Scholar
  20. Darchini-Maragheh E, Nemati-Karimooy H, Hasanabadi H et al (2012) Delayed neurological complications of sulphur mustard and tabun poisoning in 43 Iranian veterans. Basic Clin Pharmacol Toxicol 111(6):426–432. doi: 10.1111/j.1742-7843.2012.00922.x CrossRefPubMedGoogle Scholar
  21. Dunlop BW, Davis PG (2008) Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a review. Prim Care Companion J Clin Psychiatry 10(3):222–228CrossRefPubMedPubMedCentralGoogle Scholar
  22. Ebadi A, Ahmadi F, Ghanei M et al (2009) Spirituality: a key factor in coping among Iranians chronically affected by mustard gas in the disaster of war. Nurs Health Sci 11(4):344–350CrossRefPubMedGoogle Scholar
  23. Ebadi A, TayebMoradian T, Mollahadi M et al (2014) Quality of life in Iranian chemical warfare veteran’s. Iran Red Crescent Med J 16(5):e5323PubMedPubMedCentralGoogle Scholar
  24. Ehlers A (2003) Stress-related and adjustment disorders. In: Gelder MG, Lopez-Ibor JJ, Andreasen N (eds) New oxford textbook of psychiatry, 1st edn. Oxford University Press, OxfordGoogle Scholar
  25. Falahati F, Khateri S, Soroush MR et al (2010) Late psychological impacts of wartime low level exposure to sulfur mustard on civilian population of Direh (17 years after exposure). Global J Med Res 1(1):42–46Google Scholar
  26. Gabbard GO (2007) Gabbard’s treatments of psychiatric disorders, 4th edn. American Psychiatric Publishing, ArlingtonCrossRefGoogle Scholar
  27. Ghaedi G, Ghasemi H, Mousavi B et al (2012) Impact of psychological problems in chemical warfare survivors with severe ophthalmologic complication, a cross sectional study. Health Qual Life Outcomes 10:36. doi: 10.1186/1477-7525-10-36 CrossRefPubMedPubMedCentralGoogle Scholar
  28. Ginzburg K, Ein-Dor T, Solomon Z (2010) Comorbidity of posttraumatic stress disorder, anxiety and depression: a 20-year longitudinal study of war veterans. J Affect Disord 123(1–3):249–257. doi: 10.1016/j.jad.2009.08.006 CrossRefPubMedGoogle Scholar
  29. Greenwood BN, Thompson RS, Opp MR et al (2014) Repeated exposure to conditioned fear stress increases anxiety and delays sleep recovery following exposure to an acute traumatic stressor. Front Psychiatry 5:146. doi: 10.3389/fpsyt.2014.00146 CrossRefPubMedPubMedCentralGoogle Scholar
  30. Guyatt GH, Veldhuyzen Van Zanten SJ, Feeny DH et al (1989) Measuring quality of life in clinical trials: a taxonomy and review. Can Med Assoc J 140(12):1441–1448Google Scholar
  31. Hales RE, Yodofsky SC, Gabbard GO (eds) (2008) Textbook of psychiatry, 5th edn. American Psychiatric Publishing, ArlingtonGoogle Scholar
  32. Hardy P, Gorwood P (1993) Impact of life events in the course of depression. Encéphale 19(3):481–489PubMedGoogle Scholar
  33. Hashemian F, Khoshnood K, Desai MM et al (2006) Anxiety, depression, and posttraumatic stress in Iranian survivors of chemical warfare. JAMA 296(5):560–566CrossRefPubMedGoogle Scholar
  34. Hennessy CH, Moriarty DG, Zack MM et al (1994) Measuring health-related quality of life for public health surveillance. Public Health Rep 109(5):665–672PubMedPubMedCentralGoogle Scholar
  35. Henningsen P, Zimmermann T, Sattel H (2003) Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med 65(4):528–533CrossRefPubMedGoogle Scholar
  36. Holisaz M (2006) Peripheral neuropathy in chemical warfare victims. Int J Rescue Disaster Med 6(1):1–5Google Scholar
  37. Horinouchi Y, Nagayama H (2001) Role of life events on onset of major depression. Nihon Rinsho 59(8):1471–1476PubMedGoogle Scholar
  38. Jankowski MK, Schnurr PP, Adams GA et al (2004) A mediational model of PTSD in World War II veterans exposed to mustard gas. J Trauma Stress 17(4):303–310CrossRefPubMedGoogle Scholar
  39. Karami GR, Ameli J, Roeintan R et al (2013) Impacts of mustard gas exposure on veterans mental health: a study on the role of education. Ind Psychiatry J 22(1):22–25. doi: 10.4103/0972-6748.123604 CrossRefPubMedPubMedCentralGoogle Scholar
  40. Kendler KS, Karkowski LM, Prescott CA (1999) Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 56(6):837–841CrossRefGoogle Scholar
  41. Kessing LV, Bukh JD (2013) Genetics and stressful life events interact in depression. Ugeskr Laeger 175(14):948–951PubMedGoogle Scholar
  42. Lam RW, Kennedy SH, Grigoriadis S et al (2009) Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord 117:S26–S43CrossRefPubMedGoogle Scholar
  43. Lotti M, Moretto A (1999) Promotion of organophosphate induced delayed polyneuropathy by certain esterase inhibitors. Chem Biol Interact 119–120:519–524CrossRefPubMedGoogle Scholar
  44. Madarshahian F, Hassanabadi M (2009) Sleep disturbances in chemical and non-chemical war victims (Persian). Iran J War Public Health 2(5):27–32Google Scholar
  45. McNally RJ (2009) Posttraumatic stress disorder. In: Sadock BJ, Sadock VA, Ruiz P (eds) Kaplan and Sadock’s comprehensive textbook of psychiatry, 9th edn. Lippincott, Williams and Wilkins, Philadelphia, pp 2650–2660Google Scholar
  46. Mohaghegh-Motlagh SJ, Arab A, Momtazi S et al (2012) Psychological assessment of chemical injured war veterans compared to non-chemical injured war veterans. Asia-Pac Psychiatry 4:189–194CrossRefGoogle Scholar
  47. Mousavi B, Soroush MR, Montazeri A (2009) Quality of life in chemical warfare survivors with ophthalmologic injuries: the first results form Iran Chemical Warfare Victims Health Assessment Study. Health Qual Life Outcomes 7:2. doi: 10.1186/1477-7525-7-2 CrossRefPubMedPubMedCentralGoogle Scholar
  48. Namazi S, Niknahad H, Razmkhah H (2009) Long-term complications of sulphur mustard poisoning in intoxicated Iranian veterans. J Med Toxicol 5(4):191–195CrossRefPubMedPubMedCentralGoogle Scholar
  49. National Institute For Health and Clinical Excellence (2009) Depression in adults: the treatment and management of depression in adults (PDF). In: NICE clinical guidelines [CG90]. National Institute of Health and Care Excellence (NICE). Available via: http://www.nice.org.uk/guidance/cg90. Accessed 12 Dec 2014
  50. National Institute For Health and Clinical Excellence (2011) Generalized anxiety disorder and panic disorder (with or without agoraphobia) in adults: management in primary, secondary and community care (PDF). In: NICE clinical guidelines [CG113]. National Institute of Health and Care Excellence (NICE). Available via: http://www.nice.org.uk/guidance/cg113. Accessed 12 Dec 2014
  51. Newmark J (2007) Nerve agents. Neurologist 13:20–32CrossRefPubMedGoogle Scholar
  52. O’Donnell ML, Creamer M, Pattison P (2004) Posttraumatic stress disorder and depression following trauma: understanding comorbidity. Am J Psychiatry 16:1390–1396CrossRefGoogle Scholar
  53. Page WF (2003) Long-term health effects of exposure to sarin and other anticholinesterase chemical warfare agents. Mil Med 168:239–245PubMedGoogle Scholar
  54. Parchami M (1994) Objective evaluation of delayed complications of psychiatric and respiratory systems in 1500 sulfur mustard exposed Iranian veterans. Dissertation, Mashhad Medical University of SciencesGoogle Scholar
  55. Parikh SV, Segal ZV, Grigoriadis S et al (2009) Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication. J Affect Disord 117:S15–S25CrossRefPubMedGoogle Scholar
  56. Perrotta DM (1996) Environment Committee Armed Forces Epidemiological Board long-term health effects associated with sub-clinical exposures to GB and mustard. Office of the Special Assistant for Gulf War Illnesses, Gulflink. Available at www.gulflink.osd.mil/agent.html
  57. Pompili M, Sher L, Serafini G et al (2013) Posttraumatic stress disorder and suicide risk among veterans: a literature review. J Nerv Ment Dis 201(9):802–812. doi: 10.1097/NMD.0b013e3182a21458 CrossRefPubMedGoogle Scholar
  58. Prinz U, Nutzinger DO, Schulz H et al (2013) Comparative psychometric analyses of the SCL-90-R and its short versions in patients with affective disorders. BMC Psychiatry 13:104. doi: 10.1186/1471-244X-13-104 CrossRefPubMedPubMedCentralGoogle Scholar
  59. Razavi SM, Salamati P, Saghafinia M et al (2012) A review on delayed toxic effects of sulfur mustard in Iranian veterans. Daru 20(1):51. doi: 10.1186/2008-2231-20-51 CrossRefGoogle Scholar
  60. Riddle JR, Brown M, Smith T et al (2003) Chemical warfare and the Gulf War: a review of the impact on Gulf veterans’ health. Mil Med 168(8):606–613PubMedGoogle Scholar
  61. Rojas SM, Bujarski S, Babson KA et al (2014) Understanding PTSD comorbidity and suicidal behavior: associations among histories of alcohol dependence, major depressive disorder, and suicidal ideation and attempts. J Anxiety Disord 28(3):318–325. doi: 10.1016/j.janxdis.2014.02.004 CrossRefPubMedGoogle Scholar
  62. Roshan R, Rahnama P, Ghazanfari Z et al (2013) Long-term effects of sulfur mustard on civilians’ mental health 20 years after exposure (The Sardasht-Iran Cohort Study). Health Qual Life Outcomes 11:69. doi: 10.1186/1477-7525-11-69 CrossRefPubMedPubMedCentralGoogle Scholar
  63. Rustad JK, Musselman DL, Nemeroff CB (2011) The relationship of depression and diabetes: pathophysiological and treatment implications. Psychoneuroendocrinology 36(9):1276–1286CrossRefPubMedGoogle Scholar
  64. Sadock BJ, Sadock VA, Ruiz P (2014) Kaplan & Sadock’s synopsis of psychiatry: behavioral sciences/clinical psychiatry, 11th edn. Lippincott Williams and Wilkins, PhiladelphiaGoogle Scholar
  65. Schaffer A, McIntosh D, Goldstein BI et al (2012) The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders. Ann Clin Psychiatry 24(1):6–22PubMedGoogle Scholar
  66. Schnurr PP, Friedman MJ, Green BL (1996) Post-traumatic stress disorder among World War II mustard gas test participants. Mil Med 161(3):131–136PubMedGoogle Scholar
  67. Schnurr PP, Ford JD, Friedman MJ et al (2000) Predictors and outcomes of posttraumatic stress disorder in World War II veterans exposed to mustard gas. J Consult Clin Psychol 68(2):258–268CrossRefPubMedGoogle Scholar
  68. SiratiNir M, Ebadi A, FallahiKhoshknab M et al (2013) Spiritual experiences of war veterans who suffer from combat-related post-traumatic stress disorder: a qualitative study. J Relig Health 52(3):719–729. doi: 10.1007/s10943-012-9629-2 CrossRefGoogle Scholar
  69. Tabatabaee SM (1988) Study of psychiatric complications of poisoning with chemical warfare agents. Paper presented at the First International Medical Congress on Chemical Warfare Agents in Iran, Mashhad University of Medical Sciences, Mashhad, 13–16 June 1988Google Scholar
  70. Tavallaie SA, Assari SH, Najafi M et al (2005) Study of sleep quality in chemical-warfare-agents exposed veterans. J Mil Med 6(4):241–248Google Scholar
  71. Tavallaie SA, Asari S, Habibi M (2006a) Subjective sleep quality in chemical warfare veterans. Iran J Psychiatry Clin Psychol 12:263–269Google Scholar
  72. Tavallaie SA, Ghanei M, Assari SH et al (2006b) Risk factors correlated to suicide in deceased Iranian veterans. J Mil Med 8(2):143–148Google Scholar
  73. The WHOQOL group (1998) The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 46(12):1569–1585CrossRefGoogle Scholar
  74. Ursano RJ, Bell C, Eth S et al (2004) Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. In: American Psychiatric Association (ed) Practice guidelines for the treatment of psychiatric disorders. American Psychiatric Publishing, ArlingtonGoogle Scholar
  75. Vafaee B, Seidy A (2004) Prevalence of depression among physically disabled veterans in northwestern Iran. Iran J Med Sci 29(1):43–44Google Scholar
  76. Vieweg WVR, Julius DA, Fernandez A et al (2006) Posttraumatic stress disorder: clinical features, pathophysiology, and treatment. Am J Med 119(5):383–390CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Mohammad Reza Fayyazi Bordbar
    • 1
    Email author
  • Farhad Faridhosseini
    • 1
  • Ali Saghebi
    • 1
  1. 1.Department of PsychiatryPsychiatry and Behavioral Sciences Research Center, Mashhad University of Medical SciencesMashhadIran

Personalised recommendations